🏛️ Verified NIH Record • Updated 2026-01-08
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer (NCT05210283)
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Exact Sciences Corporation
🩺 Plain-English Summary (8th-Grade Level)
The CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer. Maximum duration of participant participation is up to seven years from enrollment to study completion with up to five years of active follow up and up to two years of clinical (passive) follow up.
Who can join: Review the eligibility criteria below.
Location: Facey Medical Group - Mission Hills - Endoscopy Center & Gastroenterology — Mission Hills, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (32 Sites)
Showing the first 25 of 32 sites.
- Facey Medical Group - Mission Hills - Endoscopy Center & Gastroenterology — Mission Hills, California
- Torrance Memorial Hunt Cancer Institute — Torrance, California
- University of Florida Division of Hematology & Oncology — Gainesville, Florida
- Mount Sinai Medical - Comprehensive Cancer Center — Miami Beach, Florida
- Mid Florida Cancer Centers — Orange City, Florida
- Edward Cancer Center — Elmhurst, Illinois
- Illinois Cancer Care — Peoria, Illinois
- Mercy Medical Center — Cedar Rapids, Iowa
- University of Kansas Cancer Center — Westwood, Kansas
- MedStar Georgetown Cancer Institute at MedStar Georgetown University Hospital — Baltimore, Maryland
- Meritus Center for Clinical Research — Hagerstown, Maryland
- University of Maryland St. Joseph Medical Center — Towson, Maryland
- Metro Minnesota Community Oncology Consortium (MMCORC) — Saint Louis Park, Minnesota
- Missouri Baptist Medical Center — St Louis, Missouri
- Atrium Health Levine Cancer Institute — Charlotte, North Carolina
- FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina
- Atrium Health Wake Forest Baptist Medical Center — Winston-Salem, North Carolina
- Sanford Roger Maris Cancer Center — Fargo, North Dakota
- Columbus NCORP — Columbus, Ohio
- Interstate Medical Office Central — Portland, Oregon
- UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
- Reading Hospital Hematology Oncology — West Reading, Pennsylvania
- Lankenau Medical Center — Wynnewood, Pennsylvania
- WellSpan York Cancer Center — York, Pennsylvania
- Primsa Health Cancer Institute — Greenville, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer
- Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes — Los Angeles, California
- A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors — Duarte, California
- Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) — Houston, Texas
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver — Basking Ridge, New Jersey
- The PRIME-CRC Trial to Promote CRC Screening in Rural Communities — Bastrop, Louisiana
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer — Concord, California
Explore by condition: All Colorectal Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.